At this time, no generic Bystolic (nebivolol) products are available on the market. The earliest predictable date that a generic version of this medication could become available is June 2015, when the first patent for Bystolic expires. Until an approved generic drug is available, you should not purchase any so-called generic versions, which could be fake and potentially dangerous.
Is There a Generic Version of Bystolic?
Bystolic® (nebivolol) is a prescription medication that belongs to a group of drugs known as beta blockers. It is approved for treating high blood pressure.
Bystolic is manufactured by Forest Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Bystolic from being manufactured in the United States. Yet, if you search the Internet for "generic Bystolic," you may find a number of companies selling it (or at least claiming to sell it). The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Bystolic may be available from another country, but there is really no way of knowing if you are actually getting genuine Bystolic. You should not buy any so-called generic versions of this medicine until an approved generic is available.
When Will Generic Bystolic Be Available?
The first patent for Bystolic currently expires in June 2015. This is the earliest predictable date that a generic version of the medicine could become available. However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as lawsuits or other patents. Once Bystolic goes off-patent, several companies likely will begin manufacturing a generic Bystolic drug.
Is Nebivolol a Generic Bystolic?
No -- nebivolol is the active ingredient in Bystolic, but is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.